These computational tools, developed over six years, were recently licensed from the University of Houston by Houston-based Eureka Genomics on an exclusive worldwide basis.
Led by UH associate professor Yuriy Fofanov, the development of these computational tools coincides with the introduction of next generation sequencing instruments. The marriage of these two technologies will benefit commercial applications in health care, food, agriculture, emerging pathogen surveillance and biotechnology, as well as the broad life science research community.
"I expect that these new computational tools will be used to design a variety of practical life science applications," Fofanov said. "In many cases, these applications previously were not addressable, as only inadequate tools were available to do so."
"Improved understanding of genetic variation should lead to faster development of a variety of new personalized medical treatments, such as individual dosage levels, which will reduce the frequency of adverse drug reactions," said Eureka Genomics COO Didier Perez.
"The University of Houston is pleased to work with Eureka. UH's Center for Industrial Partnerships works diligently to provide intellectual property licensing and collaborative research contracts that fit industry's needs," said John Warren, executive director of the CIP.
About the University of Houston
The University of Houston, Texas' premier metropolitan research and teaching institution, is home to more than 40 research centers and institutes and sponsors more than 300 partnerships with corporate, civic and governmental entities. UH, the most diverse research university in the country, stands at the forefront of education, research and service with more than 35,000 students.
To receive UH science news via e-mail, visit http://www.uh.edu/news-events/mailing-lists/sciencelistserv.php.
About Eureka Genomics
Eureka Genomics, based in Houston TX, is developing practical bioinformatics products and services that will be used by the broad life science research communities and enable companies to develop commercial applications in healthcare (diagnostic, therapeutic and vaccine), food/agriculture, biotechnology and emerging pathogen surveillance faster, easier and at lower cost than previously available. For more information about Eureka Genomics, contact Didier@eurekagenomics.com.
About the Center for Industrial Partnerships
Based at the University of Houston, the Center for Industrial Partnerships aims at catalyzing early joint collaborations with industry and economic development organizations. Its goal is to increase companies' competitiveness by fueling innovation while reducing commercialization risks. For more information about UH Center for Industrial Partnerships contact, email@example.com.